S&P 500 Sets New Record High on Christmas Eve Before Retreating to End 2025 Up 16% on the Year
S&P 500 (Index: SPX) investors enjoyed a relatively quiet, nearly news free two weeks to end 2025. The index set a new record high of 6,932.05 just before the Christmas Day holiday, before retreating 1.2% in the next week on little-to-no significant market-moving news to close out 2025 at 6,845.50. On 2026′s first day of trading, the index rose to 6,858.47, just 1.1% below its 24 December 2025 record high close, as investors started the year with little-to-no market moving news that could meaningfully alter their outlooks for the year-to-come.
And, we might add, no indication of any impending geopolitical event with the potential to reshape expectations for a global industry.
Which is to say it is quite possible we’ll be starting the first full trading week of 2026 with a bang. Since that will be a story we cover in the next edition of the S&P 500 chaos series, let’s close out 2025 properly with the final update to the alternative futures chart for 2025-Q4.
Through Friday, 2 January 2026, we find the S&P 500′s is tracking along in the middle of the new redzone forecast range we added to the chart a week earlier, which assumes investors are focusing their forward-looking attention on the current quarter of 2026-Q1.
The thing to pay attention to in the week ahead is how the expectations for oil prices change as a consequence to the weekend’s geopolitical event. To help set that stage, here are the market-moving headlines that were setting investor expectations during the past two holiday-shortened trading weeks.
- Monday, 22 December 2025
-
- Signs and portents for the U.S. economy:
- Oil settles higher on risk of disruptions to Venezuela, Russia supply
- Oil price gains after US interception of oil tanker off the coast of Venezuela over weekend
- Fed minion sees continuing their policy targeting 3% inflation as reason to hold rates steady, another minion talks about sticking around after term ends until replaced:
- Fed’s Hammack sees inflation near 3% as case for holding rates, WSJ reports
- Fed’s Miran says he will likely stay after term ends until his seat is filled
- Bigger stimulus not developing in China:
- BOJ minions / Bigger trouble developing in Japan:
- Germany’s automotive exports plunged in 2025:
- German auto exports hit hard by Trump tariffs, study shows
- German exports in machinery and autos/parts to China have declined strongly
- Wall Street finished higher to kick off the holiday shortened trading week
- Tuesday, 23 December 2025
-
- Signs and portents for the U.S. economy:
- US economic growth accelerates in third quarter
- Robust consumer spending, rising exports fuel US economic growth in third quarter
- Q3 GDP Unexpectedly Surges To 2 Year High On Soaring Health Insurance Spending
- Oil steadies as market weighs geopolitical risks against bearish fundamentals
- Copper price hits record high on concerns over tariffs and shortages
- Fed minions may ditch 2% inflation goal they haven’t met in years:
- Bigger AI developing in China:
- Bigger trouble developing in Japan, BOJ thinking about hiking rates sooner than expected:
- BOJ’s hawkish wink suggests next hike may be sooner than markets think
- S&P 500 notched a record close as Wall Street ended higher after GDP data
- Wednesday, 24 December 2025
-
- Signs and portents for the U.S. economy:
- Bigger trouble, stimulus developing in China:
- China’s farmers are up to their ears in milk
- Chinese capital Beijing further eases home buying curbs
- China widens foreign investment incentive list to stem falling inflows
- BOJ minions maybe not so sure about rate hike plans:
- Dow and S&P 500 closed at record highs on Christmas Eve
- Friday, 26 December 2025
-
- Signs and portents for the U.S. economy:
- Oil falls 2% on looming supply glut, hopes of Ukraine peace deal
- Copper Hits Record in China, Jumps in New York on Supply Concern
- BOJ’s chief minion wants higher interest rates, bigger troubles with fiscal policy developing in Japan:
- BOJ chief sees progress in hitting price goal, signals further hikes
- Japan proposes record budget spending while curbing fresh debt
- Wall Street halts five-day advance as precious metals grab the spotlight
- Monday, 29 December 2025
-
- Signs and portents for the U.S. economy:
- US pending home sales surge to highest in nearly 3 years in November, NAR says
- US economy to ride tax cut tailwind but faces risks
- Oil settles up over 2% on dented peace hopes in Ukraine, tensions in Yemen
- Bigger trouble, stimulus developing in China:
- China’s industrial profits tumble at fastest pace in over a year
- China’s finance ministry says fiscal policies will be more ‘proactive’ in 2026
- BOJ minions watching yen, markets watching BOJ minions:
- Yen strengthens after BOJ minutes, markets still eye intervention odds
- Rising Japanese Rates Are Creating New Risks For Global Markets
- U.S. stocks end lower to start the New Year’s shortened week
- Tuesday, 30 December 2025
-
- Signs and portents for the U.S. economy:
- Fed minions thinking more rate cuts, QE-like policies ahead:
- Bigger trouble, stimulus developing in China:
- Wall Street stretches tech-led sell-off into the last days of the year
- Wednesday, 31 December 2025
-
- Signs and portents for the U.S. economy:
- Bigger stimulus developing in China:
- China approves major projects and investment plans for 2026 totalling $42 billion
- China allocates initial $8.9 billion for consumer goods trade-in scheme in 2026
- China’s factory activity edges back to growth in December, private PMI shows
- China imposes curbs on beef imports to protect domestic industry
- BOJ minions look back at their success in hiking Japan’s interest rates:
- S&P 500 finishes with 16% gain in 2025
- Friday, 2 January 2026
-
- Signs and portents for the U.S. economy:
- Oil prices settle lower after biggest annual loss since 2020
- US draws bulk of state-owned investment in 2025 as assets hit record $60 trillion
- Bigger trouble, stimulus developing in China:
- Bigger trouble developing in Japan:
- Bigger trouble developing in Eurozone:
- Nasdaq falls flat, U.S. stocks battle to recover from tech sell-off to kick off 2026
The CME Group’s FedWatch Tool continues to anticipate additional quarter point rate cuts on 18 March (2026-Q1) and 29 July (2026-Q3), with no other rate cuts projected in 2026.
The Atlanta Fed’s GDPNow tool‘s first estimate of real GDP growth in the U.S. during 2025-Q4 is +3.0%. Meanwhile, the BEA’s first official estimate of GDP in the preceding quarter of 2025-Q3 came in at 4.3%, much higher than the GDPNow tool’s final projection of +3.5% growth for that long since ended quarter.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull and bear watching the New Year’s Eve ball drop to start 2026 and screaming with fear”.
Source: https://politicalcalculations.blogspot.com/2026/01/s-500-sets-new-record-high-on-christmas.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



